May 11, 2026 · Arthritis & rheumatology (Hoboken, N.J.) · DOI: 10.1002/art.70221

T cells, the next big target in axSpA?

Listen to this summary

The authors investigate the role of various T cell subsets in the pathogenesis of axial spondyloarthritis (axSpA) and explore emerging therapeutic strategies targeting these cells. They aim to understand the complex interactions and cytokine milieu that contribute to inflammation and tissue damage in axSpA, highlighting the potential for more effective, personalized treatments that address multiple aspects of the inflammatory process.

Mansi K Aparnathi, Nigil Haroon

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play